Can You Sue a Drug Company for Side Effects? What the Law Allows
Reference Guide
Usually yes — but who made your pill matters. The Supreme Court allows warning claims against brand-name makers, has blocked most of them against generic makers, and Congress sends vaccine injuries to a special federal court first. As of October 2026 the drug news is two things: thousands of injury suits in federal MDLs, and a state settlement over generic drug prices that is taking claims until March 8, 2027.
Questions about this case?
AI Legal Assistant · free · answers in seconds · general information, not legal advice
Independent information service: Settlement Insight is not the settlement administrator, is not affiliated with or endorsed by the company named above, and is not a law firm. Submitting this form does not file a claim — it shares your information with our participating legal intake partners, who may contact you about your options.
The Short Answer: It Depends on the Drug
Can you sue a drug company for side effects? A side effect alone is not a case. A drug lawsuit usually claims the maker knew or should have known about a risk and did not warn clearly enough, or that the drug was defective. Every drug has a label; the fight is usually over whether that label told doctors and patients what the company knew.
Brand-name drugs: in Wyeth v. Levine, No. 06-1249, decided March 4, 2009, the Supreme Court held that FDA approval of a label does not block a state-law failure-to-warn claim. Its reason: an FDA rule lets brand makers “add or strengthen a warning” before the agency approves the change.
Generic drugs: generic makers cannot change their labels on their own. So in PLIVA v. Mensing, No. 09-993 (June 23, 2011), the Court held that failure-to-warn claims against generic makers are pre-empted. In Mutual Pharmaceutical v. Bartlett, No. 12-142 (June 24, 2013), it threw out a jury award of over $21 million on the same reasoning. That case was a design-defect claim against a generic maker.
Vaccines: under 42 U.S.C. § 300aa-11 you generally cannot sue a vaccine maker for more than $1,000 until you have first filed a petition with the U.S. Court of Federal Claims.
Case details
Most side-effect cases against drug makers are not class actions. They are individual injury suits, and in federal court they are often grouped into a multidistrict litigation (MDL) before one judge for pretrial work (how that differs from a class action). The Judicial Panel on Multidistrict Litigation’s report dated October 1, 2026 lists, among others:
MDL 3140, Depo-Provera, Northern District of Florida, Judge M. Casey Rodgers: 6,412 actions pending (our Depo-Provera page).
MDL 3094, GLP-1 drugs (Ozempic, Wegovy and similar), Eastern District of Pennsylvania, Judge Karen S. Marston: 4,025 pending (our GLP-1 page).
MDL 2789, proton-pump inhibitors (heartburn drugs), District of New Jersey, Judge Claire C. Cecchi: 11,404 pending.
Cases also settle outside MDLs. On October 9, 2024 GSK announced it would pay up to $2.2 billion to resolve about 80,000 Zantac cases in state courts, 93% of those pending against it. GSK admitted no liability, and the terms are confidential (Zantac status).
Status: What Is Open as of October 2026
Drug class action with a claim form: the one in the news is economic, not about side effects. A coalition of state attorneys general alleges that generic drug makers fixed prices on more than 100 generic drugs, with some increases over 1,000 percent. On October 8, 2026 New York announced the latest settlements: Mayne Pharma will pay $650,000 and Ascend Laboratories $400,000. Citron Pharma agreed to non-monetary terms because it has stopped operating. These follow earlier state settlements totaling $496.5 million, a sum that includes Sandoz. The new settlements still need court approval.
The drug settlement deadline: consumers who bought a listed generic prescription drug between May 2009 and December 2019 must file by March 8, 2027 at AGGenericDrugs.com. A separate class settlement in federal court in Pennsylvania has an earlier claim deadline, November 9, 2026, at GenericDrugsEndPayerSettlement.com. Full details are in our news report on the settlement.
Latest From the Court Docket
Recent entries in the federal cases behind this page, taken from the court's own docket. We check it at least once a day; this list is as of Oct 17, 2026.
Oct 14, 2026
Daubert Hearing (2 filings)
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY …, No. 2:24-md-03094 (E.D. Pa.)
Oct 13, 2026
Order
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY …, No. 2:24-md-03094 (E.D. Pa.), ECF No. 916
Oct 9, 2026
Status Conference
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY …, No. 2:24-md-03094 (E.D. Pa.), ECF No. 913
Sep 24, 2026
ORDER - The CMCs scheduled for October , , and November , , are CANCELED
IN RE: DEPO-PROVERA (DEPOT MEDROXYPROGESTERONE ACETATE) PRODUCTS LIABILITY …, No. 3:25-md-03140 (N.D. Fla.), ECF No. 770
Sep 18, 2026
Minute Entry for proceedings held before JUDGE M CASEY RODGERS: General Causation/Daubert
IN RE: DEPO-PROVERA (DEPOT MEDROXYPROGESTERONE ACETATE) PRODUCTS LIABILITY …, No. 3:25-md-03140 (N.D. Fla.), ECF No. 765
Both dockets with recent entries
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY …
No. 2:24-md-03094 · E.D. Pa. · latest entry Oct 14, 2026
Docket on CourtListenerIN RE: DEPO-PROVERA (DEPOT MEDROXYPROGESTERONE ACETATE) PRODUCTS LIABILITY …
No. 3:25-md-03140 · N.D. Fla. · latest entry Oct 2, 2026
Docket on CourtListener
A docket entry is a step in the case, not a decision on who wins. Sources: the courts' PACER feeds and CourtListener (Free Law Project). Not legal advice.
Do You Have a Case? Three Questions
1. Was it a known risk the label left out? A side effect printed on the label you were given is much harder to sue over than one the company allegedly knew about and did not disclose.
2. Brand or generic? Look at your pharmacy label or receipt. If the pharmacy gave you a generic, Mensing and Bartlett block most warning-based claims against the generic maker.
3. Are you still within the deadline? Every state sets its own filing deadline for injury claims (statute of limitations by state). Lawyers in a drug MDL usually ask for prescription records and medical records that tie the drug to the diagnosis.
For the price-fixing settlement you need no injury, only the purchase of a listed generic in the May 2009 to December 2019 window.
What Drug Cases Pay
The generic price-fixing settlements are small per person. The latest three add about $1 million spread across many states, so expect a modest refund rather than compensation for harm.
Drug Lawsuit Timeline: The Rulings and Cases That Set the Rules
March 4, 2009 — Brand-Name Makers Can Be Sued Over Warnings
Wyeth v. Levine: the Supreme Court holds that FDA approval of a label does not block a state failure-to-warn claim against a brand-name maker.
June 23, 2011 — Generic Makers Get Different Treatment
PLIVA v. Mensing: failure-to-warn claims against generic manufacturers are pre-empted, because generic makers cannot change their labels on their own.
June 24, 2013 — Bartlett Extends the Generic Rule
Mutual Pharmaceutical v. Bartlett: design-defect claims that turn on a drug’s warnings are also pre-empted. A jury award of over $21 million is reversed.
October 9, 2024 — GSK Settles Zantac State Cases
GSK announces agreements covering about 80,000 state-court Zantac cases for up to $2.2 billion, with no admission of liability.
October 1, 2026 — Federal MDL Count
The JPML report lists 6,412 pending Depo-Provera actions (MDL 3140) and 4,025 GLP-1 actions (MDL 3094).
October 8, 2026 — Generic Price-Fixing Settlements
States announce $650,000 from Mayne and $400,000 from Ascend. The consumer claim deadline is March 8, 2027.
Three Things to Watch For
Drug lawsuits draw heavy advertising, and the claim deadlines (November 9, 2026 and March 8, 2027) leave room for imposters:
“Generic drug refund” messages asking for a fee
The state settlement is filed through AGGenericDrugs.com, and filing a claim is free. Texts or calls asking for a processing fee, or for your bank login, to release a “generic drug refund” are not from the administrator.
“You qualify for the Ozempic or Depo-Provera settlement”
As of October 2026 those MDLs have no settlement fund and no claim form. Anyone telling you a payout is waiting is describing something that does not exist.
Lead forms that want your medical records first
Many “check if you qualify” drug lawsuit forms are run by lead sellers, not law firms or courts. Before you upload prescriptions or records, find out who receives them and whether you are signing a retainer.
Drug Lawsuits — Questions People Actually Ask
Short answers to the questions people ask most about this case.
Can you sue a drug company for side effects?
Often yes, if you claim the company failed to warn about a risk or sold a defective drug, and if you are within your state’s deadline. Under Wyeth v. Levine (2009), FDA approval does not shield a brand-name maker from a failure-to-warn claim. The big exceptions are generic drugs and vaccines.
Can different drug manufacturers be sued over the same side effects?
Not equally. Brand-name makers can be sued over warnings. Generic makers mostly cannot, because the Supreme Court held in PLIVA v. Mensing (2011) and Mutual Pharmaceutical v. Bartlett (2013) that federal law requires them to copy the brand label. So two people with the same side effect may have very different cases depending on whether the pharmacy dispensed brand or generic.
Can I sue if I was given the wrong medication?
That is a different situation, and this page does not cover it. FDA defines a medication error as a preventable event while the medicine is in the control of a healthcare provider, patient or consumer, so the claim is about whoever made the mistake, not the drug’s maker. A medical-malpractice or pharmacy-negligence attorney is the right contact, and you can report the error to FDA’s MedWatch program.
Has anyone ever sued the FDA?
Yes. A group of medical associations and doctors sued the FDA over its rules for the abortion drug mifepristone. On June 13, 2024, in FDA v. Alliance for Hippocratic Medicine, No. 23-235, the Supreme Court held that the plaintiffs lacked standing. Suits against the FDA challenge agency decisions. They are not a route to compensation for a side effect.
Is there a drug class action I can join with a claim form?
The open one is the generic drug price-fixing settlement brought by state attorneys general. It covers people who bought listed generics between May 2009 and December 2019, and the states’ claim deadline is March 8, 2027. A separate class settlement in Pennsylvania federal court has an earlier deadline, November 9, 2026. Side-effect cases such as Depo-Provera and GLP-1 are MDLs. They have no claim form, and each person files their own lawsuit.
What about vaccine side effects?
Federal law sends those to the Vaccine Injury Compensation Program first. Under 42 U.S.C. § 300aa-11, you cannot sue a vaccine maker for more than $1,000 until a petition has been filed with the U.S. Court of Federal Claims.
What type of lawyer sues pharmaceutical companies?
Product-liability or mass-tort lawyers, usually paid a share of any recovery. We do not recommend firms. How to find and vet a personal injury lawyer explains what to ask. For gabapentin, see our gabapentin page before answering any ad.
What should I do right now if I think a drug hurt me?
Do not stop a prescribed drug without talking to your doctor. Get your pharmacy records showing the drug name, maker and dates, and keep your medical records. Report the reaction to FDA’s MedWatch, which takes reports from patients and consumers. Then check your state’s filing deadline.
About This Information
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology. Reviewed by Leonard Goldberg, Editor · Last updated - $236 billion in real payouts analyzed · See what we found
This page is for general information only and is not legal advice. Lawsuit status, eligibility, and compensation can change. Settlement Insight is not a law firm and does not represent any party. Consult a licensed attorney about your specific situation.
Related Consumer Brand Lawsuits
Other cases and free tools — not about this case.
Similar cases we track
- Open Class Action SettlementsSettlements taking claims now, with deadlines
- Class Action vs. Mass TortWhy injury cases from a drug are usually filed one by one
- Statute of Limitations by StateHow long you have to file, state by state
- Settlement Payout CalculatorEstimate what a class settlement might pay per person